Sana Biotechnology, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sana Biotechnology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
  • Sana Biotechnology, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $6.63M, a 41.7% decline year-over-year.
  • Sana Biotechnology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $30.9M, a 17.5% decline year-over-year.
  • Sana Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $37.7M, a 6.04% increase from 2023.
  • Sana Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $35.5M, a 7.31% decline from 2022.
  • Sana Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $38.3M, a 71.4% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $37.7M +$2.15M +6.04% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-17
2023 $35.5M -$2.8M -7.31% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-17
2022 $38.3M +$16M +71.4% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-17
2021 $22.4M +$16.5M +284% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $5.83M +$4.33M +289% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $1.5M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.